The Current Ratio as of November 2024 (TTM) for Luye Pharma Group Ltd. (LYPHF) is 1.32

According to Luye Pharma Group Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.32. This represents a change of 6.74% compared to the average of 1.23 of the last 4 quarters.

Luye Pharma Group Ltd. (LYPHF) Historical Current Ratio (quarterly & annually)

How has LYPHF Current Ratio performed in the past?

The mean historical Current Ratio of Luye Pharma Group Ltd. over the last ten years is 2.08. The current 1.32 Current Ratio has changed 6.24% with respect to the historical average. Over the past ten years (40 quarters), LYPHF's Current Ratio was at its highest in in the December 2015 quarter at 4.85. The Current Ratio was at its lowest in in the March 2009 quarter at 0.

Luye Pharma Group Ltd. (LYPHF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Luye Pharma Group Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Luye Pharma Group Ltd. (LYPHF) Average Current Ratio

How has LYPHF Current Ratio performed in the past?

The current Current Ratio of Luye Pharma Group Ltd. (LYPHF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Luye Pharma Group Ltd. (LYPHF) Current Ratio vs. Peers

How is LYPHF’s Current Ratio compared to its peers?

Luye Pharma Group Ltd.’s Current Ratio is greater than Astellas Pharma Inc. (0.90), greater than Sanofi (1.00), less than Amarin Corporation plc (3.23), greater than Novartis AG (1.11), greater than Scilex Holding Company (0.20), greater than Biogen Inc. (1.26), greater than Gilead Sciences, Inc. (1.11), greater than AstraZeneca PLC (0.89), greater than Johnson & Johnson (1.03), greater than Bristol-Myers Squibb Company (1.24), greater than AbbVie Inc. (0.31), greater than Eli Lilly and Company (1.27), greater than Pfizer Inc. (1.00), less than Merck & Co., Inc. (1.36),

Build a custom stock screener for Luye Pharma Group Ltd. (LYPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Luye Pharma Group Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Luye Pharma Group Ltd. (LYPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Luye Pharma Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.